Neuroprotective Effects of Rutin in Streptozotocin-Induced Diabetic Rat Retina

Journal of Molecular Neuroscience

Volumn 56, Issue 2, 2015, Pages 440-448

  Ola, Mohammad Shamsul ^a   Ahmed, Mohammed M ^b   Ahmad, Rehan ^c   Abuohashish, Hatem M ^b   Al Rejaie, Salim S ^b   Alhomida, Abdullah S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidant; Neurodegeneration; Neurotrophic factor; Retina; Rutin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; GLUCOSE; GLUTATHIONE; INSULIN; NERVE GROWTH FACTOR; PROTEIN BCL 2; RUTOSIDE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DENSITOMETRY; DIABETIC RETINOPATHY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IMMUNOBLOTTING; INSULIN BLOOD LEVEL; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING; WISTAR RAT; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; RETINA;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; HYPOGLYCEMIC AGENTS; INSULIN; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RETINA; RUTIN;

EID: 84930480483     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-015-0561-2     Document Type: Article

References (59)

1. Al-Gayyar MM, Matragoon S, Pillai BA, Ali TK, Abdelsaid MA, El-Remessy AB (2011) Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes. Diabetologia 54:669–680
2. Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes. Diabetes 57:889–898
3. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA, JDRF Diabetic Retinopathy Center Group (2006) Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401–2411
4. Babu PV, Liu D, Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 11:1777–1789
5. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791
6. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52(2):1156–1163
7. Binder DK, Scharfman HE (2004) Brain derived neurotrophic factor. Growth Factors 22:123–131 64:214–219, Biomed Pharmacother
8. Cervantes-Laurean D, Schramm DD, Jacobson EL, Halaweish I, Bruckner GG, Boissonneault GA (2006) Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 17:531–540
9. Coskun O, Kanter M, Korkmaz A, Oter S (2005) Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 51:117–123
10. Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043
11. Cunha C, Brambilla R, Thomas KL (2010) A simple role for BDNF in learning and memory? Front Mol Neurosci 3:1
12. Dajas F, Rivera-Megre F, Blasina F, Arredondo F, Abin-Carriquiry JA, Costa G, Echeverry C, Lafon L, Heizen H, Ferreira M, Morquio A (2003) Neuroprotection by xavonoids. Braz J Med Biol Res 36:1613–1620
13. De Nicoló S, Tarani L, Ceccanti M et al (2013) Effects of olive polyphenol administration on nerve growth factor and brain derived neurotrophic factor in the mouse brain. Nutrition 29:681–687
14. Fernandes AA, Novelli EL, Okoshi K, Okoshi MP, Di Muzio BP, Guimarães JF, Fernandes JA (2010) Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed Pharmacother 64:214–219
15. Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, Agrawal P, Saxena R, Srivastava S (2011) Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther 27:123–130
16. Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–1148
17. Hosseinzadeh H, Nassiri-Asl M (2014) Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J Endocrinol Invest 37:783–788, Invest 102:783–791
18. Jung UJ, Lee MK, Jeong KS, Choi MS (2004) The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 134:2499–2503
19. Kamalakkannan N, Prince PS (2006a) Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin Pharmacol Toxicol 98:97–103
20. Kamalakkannan N, Prince PS (2006b) Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 293:211–219
21. Khan MM, Ahmad A, Ishrat T, Khuwaja G, Srivastawa P, Khan MB, Raza SS, Javed H, Vaibhav K, Khan A, Islam F (2009) Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 1292:123–135
22. Khan RA, Khan MR, Sahreen S (2012) Protective effects of rutin against potassium bromate induced nephrotoxicity in rats. BMC Complement Altern Med 12:204
23. Koda T, Kuroda Y, Imai H (2009) Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines: protective effect of rutin against toxicant-induced hippocampal injury. Cell Mol Neurobiol 29:523–531
24. Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:43603
25. Kowluru RA, Kanwar M (2007) Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 16:4–8
26. Kowluru RA, Chakrabarti S, Chen S (2004) Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina. Acta Diabetol 41:194–199
27. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM (1998) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 47:815–820
28. Liu YJ, Zhan J, Liu XL, Wang Y, Ji J, He QQ (2013) Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr 33:59–63
29. Lu J, Wu DM, Hu B, Zheng YL, Zhang ZF, Wang YJ (2010) NGF-dependent activation of TrkA pathway: a mechanism for the neuroprotective effect of troxerutin in D-galactose-treated mice. Brain Pathol 20:952–965
30. Machawal L, Kumar A (2014) Possible involvement of nitric oxide mechanism in the neuroprotective effect of rutin against immobilization stress induced anxiety like behaviour, oxidative damage in mice. Pharmacol Rep 66:15–21
31. Magalingam KB, Radhakrishnan A, Haleagrahara N (2013) Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int J Mol Med 32:235–240
32. Magalingam KB, Radhakrishnan A, Ramdas P, Haleagrahara N (2015) Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson’s disease. J Mol Neurosci 55(3):609–617
33. Manach C, Morand C, Demigné C, Texier O, Régérat F, Rémésy C (1997) Bioavailability of rutin and quercetin in rats. FEBS Lett 409:12–16
34. Mohr S, Xi X, Tang J, Kern TS (2002) Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51:1172–1179
35. Muriach M, Bosch-Morell F, Alexander G, Blomhoff R, Barcia J, Arnal E, Almansa I, Romero FJ, Miranda M (2006) Lutein effect on retina and hippocampus of diabetic mice. Free Radic Biol Med 41:979–984
36. Na JY, Kim S, Song K, Kwon J (2013) Rutin alleviates neurodegeneration through inhibiting apoptotic pathway activation in dopaminergic neuronal cells. Cell Mol Neurobiol 34(7):1071–1079
37. Nakayama M, Aihara M, Chen YN, Araie M, Tomita-Yokotani K, Iwashina T (2011) Neuroprotective effects of flavonoids on hypoxia-, glutamate-, and oxidative stress-induced retinal ganglion cell death. Mol Vis 17:1784–1793
38. Ola MS, Berkich DA, Xu Y, King MT, Gardner TW, Simpson I, LaNoue KF (2006) Analysis of glucose metabolism in diabetic rat retinas. Am J Physiol Endocrinol Metab 290:E1057–E1067
39. Ola MS, Nawaz MI, Siddiquei MM et al (2012) Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy. J Diabetes Complicat 26:56–64
40. Ola MS, Ahmed MM, Abuohashish HM, Al-Rejaie SS, Alhomida AS (2013a) Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. Neurochem Res 38:1572–1579
41. Ola MS, Nawaz MI, Khan HA, Alhomida AS (2013b) Neurodegeneration and neuroprotection in diabetic retinopathy. Int J Mol Sci 14:2559–2572
42. Ola MS, Aleisa AM, Al-Rejaie SS, Abuohashish HM, Parmar MY, Alhomida AS, Ahmed MM (2014) Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci 35:1003–1008
43. Ozawa Y, Sasaki M, Takahashi N, Kamoshita M, Miyake S, Tsubota K (2012) Neuroprotective effects of lutein in the retina. Curr Pharm Des 18:51–56
44. Pandey KB, Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev (5):270–278
45. Pinent M, Blay M, Bladé MC, Salvadó MJ, Arola L, Ardévol A (2004) Grape seed-derived procyanidins have an antihyperglycemic effect in streptozotocin-induced diabetic rats and insulinomimetic activity in insulin-sensitive cell lines. Endocrinology 145:4985–4990
46. Prince PS, Kannan NK (2006) Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. J Pharm Pharmacol 58:1373–1383
47. Pu F, Mishima K, Irie K, Motohashi K, Tanaka Y, Orito K, Egawa T, Kitamura Y, Egashira N, Iwasaki K, Fujiwara M (2007) Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 104:329–334
48. Rice-Evans CA, and Packer L (1998) Flavonoids in health and diseases, Marcel Dekker, New York, NY. Vol: 1, 163–177
49. Sasaki M, Ozawa Y, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K (2010) Neurodegenerative influence of oxidative stress in the retina of a murine model of diabetes. Diabetologia 53:971–979
50. Scuderi S, D’Amico AG, Castorina A, Federico C, Marrazzo G, Drago F, Bucolo C, D’Agata V (2014) Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death. J Mol Neurosci 2014(54):395–404
51. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N (2004) Involvement of brain derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 53:2412–2419
52. Sharma S, Ali A, Ali J, Sahni JK, Baboota S (2013) Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs 22:1063–1079
53. Silva KC, Rosales MA, Biswas SK, Lopes de Faria JB, Lopes de Faria JM (2009) Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 58:1382–1390
54. Silva KC, Rosales MA, Hamassaki DE, Saito KC, Faria AM, Ribeiro PA, Faria JB, Faria JM (2013) Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 54:1325–1336
55. Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 135C:357–364
56. Wagner C, Fachinetto R, Dalla Corte CL, Brito VB, Severo D, Costa DG, Morel AF, Nogueira CW, Rocha JB (2006) Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation in vitro. Brain Res 1107:192–198
57. Wagner C, Vargas AP, Roos DH, Morel AF, Farina M, Nogueira CW, Aschner M, Rocha JB (2010) Comparative study of quercetin and its two glycoside derivatives quercitrin and rutin against methylmercury (MeHg)-induced ROS production in rat brain slices. Arch Toxicol 84(2):89–97
58. World Health Organization. Diabetes Fact Sheet Number 312; WHO: Geneva, Switzerland; Available online: http://www.who.int/mediacentre/factsheets/fs312/en
59. Xu SL, Bi CW, Choi RC, Zhu KY, Miernisha A, Dong TT, Tsim KW (2013) Flavonoids induce the synthesis and secretion of neurotrophic factors in cultured rat astrocytes: a signaling response mediated by estrogen receptor. Evid Based Complement Alternat Med 2013:127075